Loading…

Human vascular endothelial cells process and present autoantigen to human T cell lines

The effectiveness of cultured human umbilical vein endothelial cells as accessory cells for T cell activation has been investigated using T cell clones and lines derived from patients with myasthenla gravis which were specific for different epitopes on the α subunit of the human acetylcholine recept...

Full description

Saved in:
Bibliographic Details
Published in:International immunology 1995-03, Vol.7 (3), p.471-479
Main Authors: Savage, Caroline O. S., Brooks, Christopher J., Harcourt, Gillian C., Picard, Jean K., King, William, Sansom, David M., Willcox, Nicholas
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c491t-b6e736aa82dc88ce9e5847ed5718544fd41ff3790ab48cd5e79465c8d9442d2c3
cites
container_end_page 479
container_issue 3
container_start_page 471
container_title International immunology
container_volume 7
creator Savage, Caroline O. S.
Brooks, Christopher J.
Harcourt, Gillian C.
Picard, Jean K.
King, William
Sansom, David M.
Willcox, Nicholas
description The effectiveness of cultured human umbilical vein endothelial cells as accessory cells for T cell activation has been investigated using T cell clones and lines derived from patients with myasthenla gravis which were specific for different epitopes on the α subunit of the human acetylcholine receptor. The endothelial cells were induced with IFN-γ to express HLA-DR and -DQ at high and low levels respectively. They could then efficiently present specific peptides of the α subunit to an HLA-DR- and an HLA-DQw5-restricted T cell line. They could also process epitopes for both T cell lines from the full-length recombinant a subunlt (r1—437) of the human acetylcholine receptor, where the known epitopes are 80 amino acid residues apart. The endothelial presentation of r1—437, but not of the peptides, was sensitive to chloroquine inhibition. Presentation appeared slightly less efficient (by 1.5- to 3.0-fold) with endothelial cells than with presenting cells from peripheral blood. This may reflect differences in accessory signalling since mAb blocking studies suggested that ligands for CD28 provided important accessory signalling by peripheral blood presenting cells while LFA-3 was used by endothelial cells.
doi_str_mv 10.1093/intimm/7.3.471
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77350184</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>14544586</sourcerecordid><originalsourceid>FETCH-LOGICAL-c491t-b6e736aa82dc88ce9e5847ed5718544fd41ff3790ab48cd5e79465c8d9442d2c3</originalsourceid><addsrcrecordid>eNqFkUFP3DAQha0KRLe0V25IFofestixnbGPBZVuJRBIBYp6sbz2pIQmzhInCP59DbviwIXTWHrfvHnWI2SPszlnRhw2cWy67hDmYi6BfyAzLitWlAJgi8yYUaLQHPRH8imlO8aYKI3YITugJNOVmJHrxdS5SB9c8lPrBoox9OMtto1rqce2TXQ19B5Toi6G_MaEcaRuGnuXD__FSMee3r54XL4s0LaJmD6T7dq1Cb9s5i65Ovl-ebwoTs9__Dz-dlp4afhYLCsEUTmny-C19mhQaQkYFHCtpKyD5HUtwDC3lNoHhWBkpbwORsoylF7skq9r35zyfsI02q5JzzFcxH5KFkAoxrV8FyyZMmVZwbsgr0AbMCKDB2_Au34aYv6t5UaaHFSbDM3XkB_6lAas7WpoOjc8Wc7sc3923Z8FK2zuLy_sb1ynZYfhFd8UlvVirTdpxMdX2Q3_bA4Pyi5u_tgjDme_1O8LeyP-A33Dpn0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>194994689</pqid></control><display><type>article</type><title>Human vascular endothelial cells process and present autoantigen to human T cell lines</title><source>Oxford University Press:Jisc Collections:Oxford Journal Archive: Access period 2024-2025</source><creator>Savage, Caroline O. S. ; Brooks, Christopher J. ; Harcourt, Gillian C. ; Picard, Jean K. ; King, William ; Sansom, David M. ; Willcox, Nicholas</creator><creatorcontrib>Savage, Caroline O. S. ; Brooks, Christopher J. ; Harcourt, Gillian C. ; Picard, Jean K. ; King, William ; Sansom, David M. ; Willcox, Nicholas</creatorcontrib><description>The effectiveness of cultured human umbilical vein endothelial cells as accessory cells for T cell activation has been investigated using T cell clones and lines derived from patients with myasthenla gravis which were specific for different epitopes on the α subunit of the human acetylcholine receptor. The endothelial cells were induced with IFN-γ to express HLA-DR and -DQ at high and low levels respectively. They could then efficiently present specific peptides of the α subunit to an HLA-DR- and an HLA-DQw5-restricted T cell line. They could also process epitopes for both T cell lines from the full-length recombinant a subunlt (r1—437) of the human acetylcholine receptor, where the known epitopes are 80 amino acid residues apart. The endothelial presentation of r1—437, but not of the peptides, was sensitive to chloroquine inhibition. Presentation appeared slightly less efficient (by 1.5- to 3.0-fold) with endothelial cells than with presenting cells from peripheral blood. This may reflect differences in accessory signalling since mAb blocking studies suggested that ligands for CD28 provided important accessory signalling by peripheral blood presenting cells while LFA-3 was used by endothelial cells.</description><identifier>ISSN: 0953-8178</identifier><identifier>EISSN: 1460-2377</identifier><identifier>DOI: 10.1093/intimm/7.3.471</identifier><identifier>PMID: 7540863</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>Accessory cells ; Amino acids ; Antigen presentation ; Antigen Presentation - drug effects ; Antigens, CD - immunology ; Autoantigens - immunology ; B7-1 Antigen - physiology ; Blood ; CD28 antigen ; CD28 Antigens - immunology ; CD58 antigen ; CD58 Antigens ; Cell activation ; Cell Adhesion Molecules - physiology ; Cell lines ; Cells, Cultured ; Chloroquine ; Chloroquine - pharmacology ; Endothelial cells ; Endothelium, Vascular - drug effects ; Endothelium, Vascular - immunology ; Epitopes ; Epitopes - immunology ; Histocompatibility antigen HLA ; HLA-DQ Antigens - immunology ; HLA-DR Antigens - immunology ; Humans ; Interferon-gamma - pharmacology ; Lymphocytes ; Lymphocytes T ; Membrane Glycoproteins - immunology ; Myasthenia ; Myasthenia gravis ; Myasthenia Gravis - immunology ; Myasthenia Gravis - pathology ; Neuromuscular junctions ; Peptide Fragments - immunology ; Peptides ; Peripheral blood ; Receptors ; Receptors, Cholinergic - immunology ; Signal Transduction ; Signaling ; T lymphocytes ; T-Lymphocytes - immunology ; Umbilical vein ; Umbilical Veins ; γ-Interferon</subject><ispartof>International immunology, 1995-03, Vol.7 (3), p.471-479</ispartof><rights>Copyright Oxford University Press(England) Mar 1995</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c491t-b6e736aa82dc88ce9e5847ed5718544fd41ff3790ab48cd5e79465c8d9442d2c3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7540863$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Savage, Caroline O. S.</creatorcontrib><creatorcontrib>Brooks, Christopher J.</creatorcontrib><creatorcontrib>Harcourt, Gillian C.</creatorcontrib><creatorcontrib>Picard, Jean K.</creatorcontrib><creatorcontrib>King, William</creatorcontrib><creatorcontrib>Sansom, David M.</creatorcontrib><creatorcontrib>Willcox, Nicholas</creatorcontrib><title>Human vascular endothelial cells process and present autoantigen to human T cell lines</title><title>International immunology</title><addtitle>Int Immunol</addtitle><description>The effectiveness of cultured human umbilical vein endothelial cells as accessory cells for T cell activation has been investigated using T cell clones and lines derived from patients with myasthenla gravis which were specific for different epitopes on the α subunit of the human acetylcholine receptor. The endothelial cells were induced with IFN-γ to express HLA-DR and -DQ at high and low levels respectively. They could then efficiently present specific peptides of the α subunit to an HLA-DR- and an HLA-DQw5-restricted T cell line. They could also process epitopes for both T cell lines from the full-length recombinant a subunlt (r1—437) of the human acetylcholine receptor, where the known epitopes are 80 amino acid residues apart. The endothelial presentation of r1—437, but not of the peptides, was sensitive to chloroquine inhibition. Presentation appeared slightly less efficient (by 1.5- to 3.0-fold) with endothelial cells than with presenting cells from peripheral blood. This may reflect differences in accessory signalling since mAb blocking studies suggested that ligands for CD28 provided important accessory signalling by peripheral blood presenting cells while LFA-3 was used by endothelial cells.</description><subject>Accessory cells</subject><subject>Amino acids</subject><subject>Antigen presentation</subject><subject>Antigen Presentation - drug effects</subject><subject>Antigens, CD - immunology</subject><subject>Autoantigens - immunology</subject><subject>B7-1 Antigen - physiology</subject><subject>Blood</subject><subject>CD28 antigen</subject><subject>CD28 Antigens - immunology</subject><subject>CD58 antigen</subject><subject>CD58 Antigens</subject><subject>Cell activation</subject><subject>Cell Adhesion Molecules - physiology</subject><subject>Cell lines</subject><subject>Cells, Cultured</subject><subject>Chloroquine</subject><subject>Chloroquine - pharmacology</subject><subject>Endothelial cells</subject><subject>Endothelium, Vascular - drug effects</subject><subject>Endothelium, Vascular - immunology</subject><subject>Epitopes</subject><subject>Epitopes - immunology</subject><subject>Histocompatibility antigen HLA</subject><subject>HLA-DQ Antigens - immunology</subject><subject>HLA-DR Antigens - immunology</subject><subject>Humans</subject><subject>Interferon-gamma - pharmacology</subject><subject>Lymphocytes</subject><subject>Lymphocytes T</subject><subject>Membrane Glycoproteins - immunology</subject><subject>Myasthenia</subject><subject>Myasthenia gravis</subject><subject>Myasthenia Gravis - immunology</subject><subject>Myasthenia Gravis - pathology</subject><subject>Neuromuscular junctions</subject><subject>Peptide Fragments - immunology</subject><subject>Peptides</subject><subject>Peripheral blood</subject><subject>Receptors</subject><subject>Receptors, Cholinergic - immunology</subject><subject>Signal Transduction</subject><subject>Signaling</subject><subject>T lymphocytes</subject><subject>T-Lymphocytes - immunology</subject><subject>Umbilical vein</subject><subject>Umbilical Veins</subject><subject>γ-Interferon</subject><issn>0953-8178</issn><issn>1460-2377</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1995</creationdate><recordtype>article</recordtype><recordid>eNqFkUFP3DAQha0KRLe0V25IFofestixnbGPBZVuJRBIBYp6sbz2pIQmzhInCP59DbviwIXTWHrfvHnWI2SPszlnRhw2cWy67hDmYi6BfyAzLitWlAJgi8yYUaLQHPRH8imlO8aYKI3YITugJNOVmJHrxdS5SB9c8lPrBoox9OMtto1rqce2TXQ19B5Toi6G_MaEcaRuGnuXD__FSMee3r54XL4s0LaJmD6T7dq1Cb9s5i65Ovl-ebwoTs9__Dz-dlp4afhYLCsEUTmny-C19mhQaQkYFHCtpKyD5HUtwDC3lNoHhWBkpbwORsoylF7skq9r35zyfsI02q5JzzFcxH5KFkAoxrV8FyyZMmVZwbsgr0AbMCKDB2_Au34aYv6t5UaaHFSbDM3XkB_6lAas7WpoOjc8Wc7sc3923Z8FK2zuLy_sb1ynZYfhFd8UlvVirTdpxMdX2Q3_bA4Pyi5u_tgjDme_1O8LeyP-A33Dpn0</recordid><startdate>19950301</startdate><enddate>19950301</enddate><creator>Savage, Caroline O. S.</creator><creator>Brooks, Christopher J.</creator><creator>Harcourt, Gillian C.</creator><creator>Picard, Jean K.</creator><creator>King, William</creator><creator>Sansom, David M.</creator><creator>Willcox, Nicholas</creator><general>Oxford University Press</general><general>Oxford Publishing Limited (England)</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QP</scope><scope>7QR</scope><scope>7T5</scope><scope>7T7</scope><scope>7TK</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>19950301</creationdate><title>Human vascular endothelial cells process and present autoantigen to human T cell lines</title><author>Savage, Caroline O. S. ; Brooks, Christopher J. ; Harcourt, Gillian C. ; Picard, Jean K. ; King, William ; Sansom, David M. ; Willcox, Nicholas</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c491t-b6e736aa82dc88ce9e5847ed5718544fd41ff3790ab48cd5e79465c8d9442d2c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1995</creationdate><topic>Accessory cells</topic><topic>Amino acids</topic><topic>Antigen presentation</topic><topic>Antigen Presentation - drug effects</topic><topic>Antigens, CD - immunology</topic><topic>Autoantigens - immunology</topic><topic>B7-1 Antigen - physiology</topic><topic>Blood</topic><topic>CD28 antigen</topic><topic>CD28 Antigens - immunology</topic><topic>CD58 antigen</topic><topic>CD58 Antigens</topic><topic>Cell activation</topic><topic>Cell Adhesion Molecules - physiology</topic><topic>Cell lines</topic><topic>Cells, Cultured</topic><topic>Chloroquine</topic><topic>Chloroquine - pharmacology</topic><topic>Endothelial cells</topic><topic>Endothelium, Vascular - drug effects</topic><topic>Endothelium, Vascular - immunology</topic><topic>Epitopes</topic><topic>Epitopes - immunology</topic><topic>Histocompatibility antigen HLA</topic><topic>HLA-DQ Antigens - immunology</topic><topic>HLA-DR Antigens - immunology</topic><topic>Humans</topic><topic>Interferon-gamma - pharmacology</topic><topic>Lymphocytes</topic><topic>Lymphocytes T</topic><topic>Membrane Glycoproteins - immunology</topic><topic>Myasthenia</topic><topic>Myasthenia gravis</topic><topic>Myasthenia Gravis - immunology</topic><topic>Myasthenia Gravis - pathology</topic><topic>Neuromuscular junctions</topic><topic>Peptide Fragments - immunology</topic><topic>Peptides</topic><topic>Peripheral blood</topic><topic>Receptors</topic><topic>Receptors, Cholinergic - immunology</topic><topic>Signal Transduction</topic><topic>Signaling</topic><topic>T lymphocytes</topic><topic>T-Lymphocytes - immunology</topic><topic>Umbilical vein</topic><topic>Umbilical Veins</topic><topic>γ-Interferon</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Savage, Caroline O. S.</creatorcontrib><creatorcontrib>Brooks, Christopher J.</creatorcontrib><creatorcontrib>Harcourt, Gillian C.</creatorcontrib><creatorcontrib>Picard, Jean K.</creatorcontrib><creatorcontrib>King, William</creatorcontrib><creatorcontrib>Sansom, David M.</creatorcontrib><creatorcontrib>Willcox, Nicholas</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>International immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Savage, Caroline O. S.</au><au>Brooks, Christopher J.</au><au>Harcourt, Gillian C.</au><au>Picard, Jean K.</au><au>King, William</au><au>Sansom, David M.</au><au>Willcox, Nicholas</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Human vascular endothelial cells process and present autoantigen to human T cell lines</atitle><jtitle>International immunology</jtitle><addtitle>Int Immunol</addtitle><date>1995-03-01</date><risdate>1995</risdate><volume>7</volume><issue>3</issue><spage>471</spage><epage>479</epage><pages>471-479</pages><issn>0953-8178</issn><eissn>1460-2377</eissn><abstract>The effectiveness of cultured human umbilical vein endothelial cells as accessory cells for T cell activation has been investigated using T cell clones and lines derived from patients with myasthenla gravis which were specific for different epitopes on the α subunit of the human acetylcholine receptor. The endothelial cells were induced with IFN-γ to express HLA-DR and -DQ at high and low levels respectively. They could then efficiently present specific peptides of the α subunit to an HLA-DR- and an HLA-DQw5-restricted T cell line. They could also process epitopes for both T cell lines from the full-length recombinant a subunlt (r1—437) of the human acetylcholine receptor, where the known epitopes are 80 amino acid residues apart. The endothelial presentation of r1—437, but not of the peptides, was sensitive to chloroquine inhibition. Presentation appeared slightly less efficient (by 1.5- to 3.0-fold) with endothelial cells than with presenting cells from peripheral blood. This may reflect differences in accessory signalling since mAb blocking studies suggested that ligands for CD28 provided important accessory signalling by peripheral blood presenting cells while LFA-3 was used by endothelial cells.</abstract><cop>England</cop><pub>Oxford University Press</pub><pmid>7540863</pmid><doi>10.1093/intimm/7.3.471</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0953-8178
ispartof International immunology, 1995-03, Vol.7 (3), p.471-479
issn 0953-8178
1460-2377
language eng
recordid cdi_proquest_miscellaneous_77350184
source Oxford University Press:Jisc Collections:Oxford Journal Archive: Access period 2024-2025
subjects Accessory cells
Amino acids
Antigen presentation
Antigen Presentation - drug effects
Antigens, CD - immunology
Autoantigens - immunology
B7-1 Antigen - physiology
Blood
CD28 antigen
CD28 Antigens - immunology
CD58 antigen
CD58 Antigens
Cell activation
Cell Adhesion Molecules - physiology
Cell lines
Cells, Cultured
Chloroquine
Chloroquine - pharmacology
Endothelial cells
Endothelium, Vascular - drug effects
Endothelium, Vascular - immunology
Epitopes
Epitopes - immunology
Histocompatibility antigen HLA
HLA-DQ Antigens - immunology
HLA-DR Antigens - immunology
Humans
Interferon-gamma - pharmacology
Lymphocytes
Lymphocytes T
Membrane Glycoproteins - immunology
Myasthenia
Myasthenia gravis
Myasthenia Gravis - immunology
Myasthenia Gravis - pathology
Neuromuscular junctions
Peptide Fragments - immunology
Peptides
Peripheral blood
Receptors
Receptors, Cholinergic - immunology
Signal Transduction
Signaling
T lymphocytes
T-Lymphocytes - immunology
Umbilical vein
Umbilical Veins
γ-Interferon
title Human vascular endothelial cells process and present autoantigen to human T cell lines
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T22%3A04%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Human%20vascular%20endothelial%20cells%20process%20and%20present%20autoantigen%20to%20human%20T%20cell%20lines&rft.jtitle=International%20immunology&rft.au=Savage,%20Caroline%20O.%20S.&rft.date=1995-03-01&rft.volume=7&rft.issue=3&rft.spage=471&rft.epage=479&rft.pages=471-479&rft.issn=0953-8178&rft.eissn=1460-2377&rft_id=info:doi/10.1093/intimm/7.3.471&rft_dat=%3Cproquest_cross%3E14544586%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c491t-b6e736aa82dc88ce9e5847ed5718544fd41ff3790ab48cd5e79465c8d9442d2c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=194994689&rft_id=info:pmid/7540863&rfr_iscdi=true